Announced Tue, 16 Jun · 15:42 IST
Investor Presentation: FY26 results, oncology expansion plans shared
Investor Communications View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.8%1-day move
₹101.90
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.8-4.7-2.1-2.5-2.8-0.9+4.5+8.0——
Up moveDown movePending
AI summary
Hannah Joseph Hospital (SME-listed, Madurai) filed its investor presentation. FY26 revenue rose 18.73% to ₹92.05 Cr; EBITDA was ₹24.96 Cr (27.12% margin) and PAT was ₹11.18 Cr, reflecting a 19% revenue and 15.07% EBITDA CAGR over FY23-26. ARPOB grew from ₹80L to ₹139L. The 133-bed hospital plans to expand into oncology/radiation with a dedicated cancer care campus on already-acquired adjacent land. Promoters hold 71.28%.
Likely market impact
Strong historical growth and clear oncology expansion roadmap are positives; however, no forward financial targets or margin guidance were disclosed.